Real-world Australian data replicate very high sustained virological response at 12 weeks (SVR12) results reported in clinical trials and suggest SVR12 is highly achievable even in those without an end-of-treatment response

Williams, J; Lucarelli, N; Pham, D; Douglas, L; Chivers, S; Day, C; Parsons, N; Trinh, A; Lewis, D; Bloom, S; Nicoll, A; Lubel, J

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017; 32 ( ): 84